| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|
| 7-carboxynalidixic acid | [no description available] | medium | 6 | 0 | naphthyridine derivative | |
| nalidixic acid | [no description available] | medium | 8 | 0 | 1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic | antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor |
| probenecid | [no description available] | medium | 1 | 0 | benzoic acids;
sulfonamide | uricosuric drug |
| t0156 | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| eupolauridine | [no description available] | low | 0 | 0 | naphthyridine derivative | metabolite |
| sophoramine | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 1,3-dichloro-7-methyl-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 6,6,7-trimethyl-1-(4-morpholinyl)-3-(phenylmethylthio)-5,8-dihydro-2,7-naphthyridine-4-carbonitrile | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 7-methyl-3-(4-morpholinyl)-1-(prop-2-enylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 7-methyl-3-(3-methylbutylamino)-1-(1-pyrrolidinyl)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 3-amino-N-tert-butyl-6-methyl-7,8-dihydro-5H-thieno[2,3-b][1,6]naphthyridine-2-carboxamide | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 2-[[4-cyano-6,6,7-trimethyl-1-(4-morpholinyl)-5,8-dihydro-2,7-naphthyridin-3-yl]thio]acetic acid methyl ester | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid (3-bromophenyl)methyl ester | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 3-(3-hydroxypropylamino)-7-methyl-1-(pentylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| [5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-yl]hydrazine | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-amine | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| 6-amino-5-cyano-2-[[(3-cyano-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-2-yl)thio]methyl]-4-(4-fluorophenyl)-4H-pyran-3-carboxylic acid methyl ester | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| sb 334867-a | [no description available] | low | 0 | 0 | naphthyridine derivative | |
| cx 5461 | [no description available] | low | 0 | 0 | diazepine;
naphthyridine derivative;
organic heterotetracyclic compound;
pyrazines;
secondary carboxamide | antineoplastic agent;
apoptosis inducer;
EC 2.7.7.6 (RNA polymerase) inhibitor |
| 9-(1-methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone | [no description available] | low | 0 | 0 | naphthyridine derivative | |